Wall Street Signals: PSYC Continues to Amass Sizable Audience Within Emerging Medicinal Psychedelics Industry

PSYC Continues to Amass Sizable Audience Within Emerging Medicinal Psychedelics Industry


PSYC’s Industry Leading media platform, Psychedelic Spotlight, Shines in May

Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) the first publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce that its Psychedelic Spotlight media platform received nearly 125K page views in the month of May setting yet another record high for the platform which had previously hit 105K page views in the month of April.

The Company contends that this encouraging data, observed from Google Analytics, demonstrates the growing audience and following it continues to amass within the emerging sector of medicinal psychedelics, and more specifically, at a time when the industry itself continues to garner more attention from the mainstream media.

"Notwithstanding the business, I really accept there is a lot of significant worth in an organization building up an enormous after and crowd," Said Global Trac Solutions, Inc. Chief, David Flores. "I think we have been very essential up to this point in our capacity to effectively use the utilization of profoundly significant data, news, narrating, and interesting viewpoint to draw in and assemble what I believe is an amazing crowd for Psychedelic Spotlight. Also, from my point of view, with the hallucinogenics business still particularly at its outset, I can't resist the urge to see the beneficial and artful position that, as I would see it, we are making for PSYC through the achievement of Psychedelic Spotlight. The energizing test currently gets two-overlap with proceeding to additionally extend our essence while likewise effectively searching out freedoms to expand its utilization and with the goal of driving however much worth into PSYC as could be expected in the years to come."

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic-inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment-related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development, we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale, or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
(702) 239-1919